Singapore markets closed

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.17-0.10 (-1.59%)
At close: 04:00PM EDT
6.08 -0.09 (-1.46%)
After hours: 04:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 971.15M
Enterprise value 562.67M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.40
Price/book (mrq)2.38
Enterprise value/revenue 9.40
Enterprise value/EBITDA -5.82

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 3-5.22%
S&P500 52-week change 326.49%
52-week high 311.31
52-week low 32.00
50-day moving average 37.40
200-day moving average 35.01

Share statistics

Avg vol (3-month) 32.78M
Avg vol (10-day) 32.78M
Shares outstanding 5154.89M
Implied shares outstanding 6154.89M
Float 8126.22M
% held by insiders 10.71%
% held by institutions 179.79%
Shares short (30 Apr 2024) 421.08M
Short ratio (30 Apr 2024) 48.08
Short % of float (30 Apr 2024) 413.68%
Short % of shares outstanding (30 Apr 2024) 413.62%
Shares short (prior month 28 Mar 2024) 411.81M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -192.61%
Operating margin (ttm)-214.00%

Management effectiveness

Return on assets (ttm)-17.13%
Return on equity (ttm)-55.19%

Income statement

Revenue (ttm)59.84M
Revenue per share (ttm)0.64
Quarterly revenue growth (yoy)10.50%
Gross profit (ttm)N/A
EBITDA -88.03M
Net income avi to common (ttm)-115.27M
Diluted EPS (ttm)-1.12
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)482.89M
Total cash per share (mrq)3.12
Total debt (mrq)74.41M
Total debt/equity (mrq)18.24%
Current ratio (mrq)21.39
Book value per share (mrq)2.64

Cash flow statement

Operating cash flow (ttm)-84.15M
Levered free cash flow (ttm)-57.92M